Dysregulated Maresin Concentrations in Plasma and Nasal Secretions From Patients With Chronic Rhinosinusitis

The mechanisms that lead to disease onset and propagation in patients with chronic rhinosinusitis (CRS) are not fully elucidated. Maresins (MaR) are a family of essential fatty acid-derived lipid mediators that play a central role in the regulation of inflammation with several studies demonstrating...

Full description

Bibliographic Details
Main Authors: Issa Beegun, Duco S. Koenis, Ghassan Alusi, Jesmond Dalli
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.733019/full
_version_ 1818609891197059072
author Issa Beegun
Duco S. Koenis
Ghassan Alusi
Jesmond Dalli
Jesmond Dalli
author_facet Issa Beegun
Duco S. Koenis
Ghassan Alusi
Jesmond Dalli
Jesmond Dalli
author_sort Issa Beegun
collection DOAJ
description The mechanisms that lead to disease onset and propagation in patients with chronic rhinosinusitis (CRS) are not fully elucidated. Maresins (MaR) are a family of essential fatty acid-derived lipid mediators that play a central role in the regulation of inflammation with several studies demonstrating that these mediators display protective activities in airway inflammation. Therefore, in the present studies we evaluated whether concentrations of these mediators were altered in both peripheral blood and nasal secretions from CRS patients. Herein, we focused on patients with CRS that also develop nasal polyps (CRSwNP), given that therapeutic options for the treatment of these patients are limited. Thereby, insights into disease mechanisms in these patients may help design more effective treatments. For this purpose, we compared maresin concentrations from CRSwNP patients with those found in healthy volunteers or patients with an upper respiratory tract infection (URTI), as a self-resolving inflammatory condition. Using liquid chromatography tandem mass spectrometry, we found that MaR concentrations were significantly decreased in plasma from patients with CRSwNP when compared to healthy volunteers. MaR concentrations were observed to be significantly upregulated in nasal secretions from patients with CRSwNP when compared with both healthy volunteers and URTI subjects. Concentration of these mediators in both plasma and nasal secretions from CRSwNP patients were positively correlated with quality-of-life scores in these patients. Assessment of the concentrations of other pro-resolving and pro-inflammatory lipid mediators (LM) demonstrated that there was a general shift in LM levels in both plasma and nasal secretions from CRSwNP when compared with healthy volunteers and URTI subjects. Of note, incubation of peripheral blood cells from CRSwNP patients with MaR1 downregulated the expression of activation markers on peripheral blood phagocytes, including CD41 and CD62P, markers of platelet-leukocyte heterotypic aggregates. Together these findings demonstrate that both local and systemic LM concentrations, in particularly those of the MaR family, become altered in patients with CRSwNP. They also suggest that therapeutics designed around MaR1 may be useful in regulating the activation of phagocytes in patients with CRSwNP thereby potentially also limiting the local inflammatory response in these patients.
first_indexed 2024-12-16T15:05:44Z
format Article
id doaj.art-c09c7549bf14447faa9c156bd891e99b
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-16T15:05:44Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-c09c7549bf14447faa9c156bd891e99b2022-12-21T22:27:09ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-08-011210.3389/fimmu.2021.733019733019Dysregulated Maresin Concentrations in Plasma and Nasal Secretions From Patients With Chronic RhinosinusitisIssa Beegun0Duco S. Koenis1Ghassan Alusi2Jesmond Dalli3Jesmond Dalli4William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United KingdomWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United KingdomWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United KingdomWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United KingdomCentre for Inflammation and Therapeutic Innovation, Queen Mary University of London, London, United KingdomThe mechanisms that lead to disease onset and propagation in patients with chronic rhinosinusitis (CRS) are not fully elucidated. Maresins (MaR) are a family of essential fatty acid-derived lipid mediators that play a central role in the regulation of inflammation with several studies demonstrating that these mediators display protective activities in airway inflammation. Therefore, in the present studies we evaluated whether concentrations of these mediators were altered in both peripheral blood and nasal secretions from CRS patients. Herein, we focused on patients with CRS that also develop nasal polyps (CRSwNP), given that therapeutic options for the treatment of these patients are limited. Thereby, insights into disease mechanisms in these patients may help design more effective treatments. For this purpose, we compared maresin concentrations from CRSwNP patients with those found in healthy volunteers or patients with an upper respiratory tract infection (URTI), as a self-resolving inflammatory condition. Using liquid chromatography tandem mass spectrometry, we found that MaR concentrations were significantly decreased in plasma from patients with CRSwNP when compared to healthy volunteers. MaR concentrations were observed to be significantly upregulated in nasal secretions from patients with CRSwNP when compared with both healthy volunteers and URTI subjects. Concentration of these mediators in both plasma and nasal secretions from CRSwNP patients were positively correlated with quality-of-life scores in these patients. Assessment of the concentrations of other pro-resolving and pro-inflammatory lipid mediators (LM) demonstrated that there was a general shift in LM levels in both plasma and nasal secretions from CRSwNP when compared with healthy volunteers and URTI subjects. Of note, incubation of peripheral blood cells from CRSwNP patients with MaR1 downregulated the expression of activation markers on peripheral blood phagocytes, including CD41 and CD62P, markers of platelet-leukocyte heterotypic aggregates. Together these findings demonstrate that both local and systemic LM concentrations, in particularly those of the MaR family, become altered in patients with CRSwNP. They also suggest that therapeutics designed around MaR1 may be useful in regulating the activation of phagocytes in patients with CRSwNP thereby potentially also limiting the local inflammatory response in these patients.https://www.frontiersin.org/articles/10.3389/fimmu.2021.733019/fullresolvingresolutioninflammationphagocytesomega-3chronic rhinosinusitis
spellingShingle Issa Beegun
Duco S. Koenis
Ghassan Alusi
Jesmond Dalli
Jesmond Dalli
Dysregulated Maresin Concentrations in Plasma and Nasal Secretions From Patients With Chronic Rhinosinusitis
Frontiers in Immunology
resolving
resolution
inflammation
phagocytes
omega-3
chronic rhinosinusitis
title Dysregulated Maresin Concentrations in Plasma and Nasal Secretions From Patients With Chronic Rhinosinusitis
title_full Dysregulated Maresin Concentrations in Plasma and Nasal Secretions From Patients With Chronic Rhinosinusitis
title_fullStr Dysregulated Maresin Concentrations in Plasma and Nasal Secretions From Patients With Chronic Rhinosinusitis
title_full_unstemmed Dysregulated Maresin Concentrations in Plasma and Nasal Secretions From Patients With Chronic Rhinosinusitis
title_short Dysregulated Maresin Concentrations in Plasma and Nasal Secretions From Patients With Chronic Rhinosinusitis
title_sort dysregulated maresin concentrations in plasma and nasal secretions from patients with chronic rhinosinusitis
topic resolving
resolution
inflammation
phagocytes
omega-3
chronic rhinosinusitis
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.733019/full
work_keys_str_mv AT issabeegun dysregulatedmaresinconcentrationsinplasmaandnasalsecretionsfrompatientswithchronicrhinosinusitis
AT ducoskoenis dysregulatedmaresinconcentrationsinplasmaandnasalsecretionsfrompatientswithchronicrhinosinusitis
AT ghassanalusi dysregulatedmaresinconcentrationsinplasmaandnasalsecretionsfrompatientswithchronicrhinosinusitis
AT jesmonddalli dysregulatedmaresinconcentrationsinplasmaandnasalsecretionsfrompatientswithchronicrhinosinusitis
AT jesmonddalli dysregulatedmaresinconcentrationsinplasmaandnasalsecretionsfrompatientswithchronicrhinosinusitis